Cognitive maintenance, age-associated neurological decline, peripheral nerve regeneration, neuroinflammation, and circadian regulation.
Bioregulatory Medicine
The clinical practice of endogenic pharmacology. The translation of the discipline into therapeutic protocols.
The clinical practice of the discipline.
Bioregulatory medicine is the clinical practice of endogenic pharmacology. Where endogenic pharmacology defines the science, bioregulatory medicine defines the practice — the translation of scientific principles into therapeutic protocols, dosing schedules, indication selection, patient stratification, and outcome measurement.
It is distinct from integrative medicine, functional medicine, or naturopathic medicine. Bioregulatory medicine is rigorously pharmacological in its mechanisms, sources its therapeutic compounds from peer-reviewed and patent-protected research, and operates through the same regulatory pathways and clinical-evidence standards as conventional pharmaceutical practice.
Five primary therapeutic domains.
T-cell competence restoration, immunosenescence, post-acute immune recovery, and the regulation of the thymus-adrenal-gonadal axis.
Endothelial function, vascular age reversal, post-event recovery, and microvascular regulation in metabolic and inflammatory states.
Telomerase regulation, senescent-cell modulation, hormonal-axis maintenance, and the integrated multi-system protocols characteristic of clinical longevity practice.
Pancreatic regulation, glucose homeostasis, hepatic function, and the metabolic-syndrome profile addressable through endogenous regulatory restoration.
Two clinical tiers.
Bioregulatory therapeutics are distributed at two tiers: opticeuticals for over-the-counter consumer access, and endoceuticals for prescription clinical use. The two tiers are governed by distinct regulatory pathways, distinct manufacturing standards, and distinct clinical-evidence requirements, and are designed to make the discipline accessible at appropriate levels of clinical supervision.